Free Trial

Chemours (CC) Competitors

Chemours logo
$11.50 -0.48 (-4.01%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$11.50 +0.01 (+0.04%)
As of 08/1/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CC vs. ASIX, CE, DD, DOW, EMN, HUN, NTR, OLN, TROX, and AXTA

Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include AdvanSix (ASIX), Celanese (CE), DuPont de Nemours (DD), DOW (DOW), Eastman Chemical (EMN), Huntsman (HUN), Nutrien (NTR), Olin (OLN), Tronox (TROX), and Axalta Coating Systems (AXTA). These companies are all part of the "basic materials" sector.

Chemours vs. Its Competitors

Chemours (NYSE:CC) and AdvanSix (NYSE:ASIX) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

In the previous week, AdvanSix had 8 more articles in the media than Chemours. MarketBeat recorded 14 mentions for AdvanSix and 6 mentions for Chemours. Chemours' average media sentiment score of 0.84 beat AdvanSix's score of 0.05 indicating that Chemours is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chemours
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AdvanSix
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Chemours currently has a consensus price target of $17.44, suggesting a potential upside of 51.69%. AdvanSix has a consensus price target of $33.50, suggesting a potential upside of 74.39%. Given AdvanSix's stronger consensus rating and higher probable upside, analysts plainly believe AdvanSix is more favorable than Chemours.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56
AdvanSix
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Chemours has higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemours$5.78B0.30$86M$0.2057.50
AdvanSix$1.52B0.34$44.15M$3.126.16

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 3.0%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.3%. Chemours pays out 175.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. AdvanSix pays out 20.5% of its earnings in the form of a dividend. AdvanSix has raised its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

76.3% of Chemours shares are held by institutional investors. Comparatively, 86.4% of AdvanSix shares are held by institutional investors. 0.5% of Chemours shares are held by company insiders. Comparatively, 5.6% of AdvanSix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

AdvanSix has a net margin of 5.45% compared to Chemours' net margin of 0.54%. Chemours' return on equity of 23.82% beat AdvanSix's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemours0.54% 23.82% 2.07%
AdvanSix 5.45%11.38%5.65%

Chemours has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500. Comparatively, AdvanSix has a beta of 1.6, suggesting that its share price is 60% more volatile than the S&P 500.

Summary

AdvanSix beats Chemours on 12 of the 19 factors compared between the two stocks.

Get Chemours News Delivered to You Automatically

Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CC vs. The Competition

MetricChemoursCHEM IndustryMaterials SectorNYSE Exchange
Market Cap$1.79B$11.13B$3.17B$20.69B
Dividend Yield2.92%3.87%5.19%3.67%
P/E Ratio57.5020.57117.7729.07
Price / Sales0.305.1430,017,513,221,196,900.0066.37
Price / Cash3.257.0623.7822.84
Price / Book2.841.565.894.43
Net Income$86M$507.45M$148.55M$994.22M
7 Day Performance-18.81%-8.97%-3.20%-3.35%
1 Month Performance-9.87%-6.62%1.47%-2.06%
1 Year Performance-43.98%-4.86%28.79%10.15%

Chemours Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CC
Chemours
4.7203 of 5 stars
$11.50
-4.0%
$17.44
+51.7%
-50.7%$1.79B$5.78B57.506,000Upcoming Earnings
Gap Down
ASIX
AdvanSix
4.1533 of 5 stars
$21.97
0.0%
$33.50
+52.5%
-28.2%$589.02M$1.52B7.041,450Trending News
Analyst Downgrade
CE
Celanese
4.6961 of 5 stars
$58.00
+1.2%
$66.50
+14.7%
-64.7%$6.35B$10.28B-3.8112,163Positive News
Ex-Dividend
Gap Down
DD
DuPont de Nemours
4.6677 of 5 stars
$76.02
+0.6%
$88.31
+16.2%
-15.5%$31.81B$12.39B-400.1124,000Positive News
Upcoming Earnings
DOW
DOW
4.4829 of 5 stars
$28.38
+0.1%
$33.47
+18.0%
-59.1%$20.06B$42.96B70.9436,000Analyst Forecast
EMN
Eastman Chemical
4.8407 of 5 stars
$77.47
-0.4%
$97.08
+25.3%
-42.2%$8.94B$9.38B9.8614,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
Gap Down
HUN
Huntsman
4.5235 of 5 stars
$11.54
+1.9%
$13.17
+14.1%
-60.1%$2.00B$5.98B-12.686,300Trending News
Earnings Report
Dividend Announcement
Analyst Revision
NTR
Nutrien
3.7214 of 5 stars
$59.23
-1.3%
$62.78
+6.0%
+17.4%$28.85B$25.97B55.3525,500Trending News
Upcoming Earnings
Analyst Forecast
Analyst Revision
OLN
Olin
4.2903 of 5 stars
$20.49
+0.5%
$27.33
+33.4%
-59.0%$2.36B$6.54B40.177,676News Coverage
Earnings Report
Analyst Forecast
Gap Down
TROX
Tronox
4.7526 of 5 stars
$5.46
-1.2%
$7.06
+29.5%
-78.3%$864.40M$3.07B-5.746,500News Coverage
Earnings Report
Insider Trade
Gap Down
AXTA
Axalta Coating Systems
4.4357 of 5 stars
$29.75
+0.2%
$38.80
+30.4%
-24.1%$6.50B$5.28B14.5112,800News Coverage
Earnings Report
Analyst Forecast

Related Companies and Tools


This page (NYSE:CC) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners